| Dr Richard Andrew Shepler Jr, MD | |
|
17240 Cortez Blvd, Brooksville, FL 34601-8921 | |
| (904) 399-5550 | |
| Not Available |
| Full Name | Dr Richard Andrew Shepler Jr |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 10 Years |
| Location | 17240 Cortez Blvd, Brooksville, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376961904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 148268 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Steward Rockledge Hospital | Rockledge, FL | Hospital |
| Melbourne Regional Medical Center | Melbourne, FL | Hospital |
| Steward Sebastian River Medical Center | Sebastian, FL | Hospital |
| Parrish Medical Center | Titusville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tower Imaging Llc | 2860470077 | 107 |
| North Brevard Medical Support Inc | 7618870296 | 87 |
| Mori Bean And Brooks Inc | 8820077878 | 633 |
News Archive
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.
The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.
"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.
› Verified 2 days ago
| Entity Name | North Brevard Medical Support Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609834886 PECOS PAC ID: 7618870296 Enrollment ID: O20040130000385 |
News Archive
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.
The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.
"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.
› Verified 2 days ago
| Entity Name | Tower Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467654244 PECOS PAC ID: 2860470077 Enrollment ID: O20040713000446 |
News Archive
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.
The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.
"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.
› Verified 2 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20040714001317 |
News Archive
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.
The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.
"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Andrew Shepler Jr, MD 8375 Dix Ellis Trl Ste 201, Jacksonville, FL 32256-8241 Ph: (904) 399-5550 | Dr Richard Andrew Shepler Jr, MD 17240 Cortez Blvd, Brooksville, FL 34601-8921 Ph: (904) 399-5550 |
News Archive
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Natera, Inc., a leader in non-invasive genetic testing, today announced that it has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures. This financing round also includes participation from Capital Research and Management, Franklin Templeton Investments, Jennison Associates, RA Capital Management, Healthcor Partners and OrbiMed Advisors.
The poor and disabled people who rely on Medicaid to pay their medical bills could be in grave jeopardy in this sour I've-got-mine political climate. Older Americans, a potent voting bloc, have made clear that they won't stand for serious changes in Medicare. Medicaid, however, provides health insurance for the most vulnerable, who have far less political clout.
"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.
› Verified 2 days ago
Harvey N Esrov, MD Radiology Medicare: Medicare Enrolled Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 813-920-5200 Fax: 813-920-5228 | |
Joseph C Sullivan Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 904-236-5884 Fax: 904-346-4334 | |
Mr. Naveen Bikkasani, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 13470 Taft St, Brooksville, FL 34613 Phone: 352-597-0016 Fax: 352-597-0089 | |
Mr. Venkata Rao Emandi, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 14535 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-3622 Fax: 352-596-0901 | |
Dr. Raymond J Perez, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 813-890-8004 Fax: 727-518-0762 | |
Mr. John Meyer Iii, Radiology Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 904-399-5800 | |
Dr. Dalila Nieves-cruz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 17240 Cortez Blvd, Brooksville, FL 34601 Phone: 352-796-5111 |